These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 29465359)
1. Socio-economic inequalities in occurrence and health care costs in rheumatic and musculoskeletal diseases: results from a Spanish population-based study including 1.9 million persons. Putrik P; Ramiro S; Orueta JF; Keszei A; Alonso Moran E; Nuño Solinis R; Boonen A Clin Exp Rheumatol; 2018; 36(4):589-594. PubMed ID: 29465359 [TBL] [Abstract][Full Text] [Related]
2. The population impact of rheumatic and musculoskeletal diseases in relation to other non-communicable disorders: comparing two estimation approaches. Simões D; Araújo FA; Monjardino T; Severo M; Cruz I; Carmona L; Lucas R Rheumatol Int; 2018 May; 38(5):905-915. PubMed ID: 29423535 [TBL] [Abstract][Full Text] [Related]
3. Patterns and Consequences of Multimorbidity in the General Population: There is No Chronic Disease Management Without Rheumatic Disease Management. Simões D; Araújo FA; Severo M; Monjardino T; Cruz I; Carmona L; Lucas R Arthritis Care Res (Hoboken); 2017 Jan; 69(1):12-20. PubMed ID: 27482954 [TBL] [Abstract][Full Text] [Related]
4. Socio-economic gradients in the presence of musculoskeletal and other chronic diseases: results from a cross-sectional study in the Netherlands. Putrik P; Ramiro S; Chorus AM; Keszei AP; Boonen A Clin Rheumatol; 2018 Dec; 37(12):3173-3182. PubMed ID: 29948350 [TBL] [Abstract][Full Text] [Related]
5. 10-year multimorbidity patterns among people with and without rheumatic and musculoskeletal diseases: an observational cohort study using linked electronic health records from Wales, UK. Jalali-Najafabadi F; Bailey R; Lyons J; Akbari A; Ba Dhafari T; Azadbakht N; Rafferty J; Watkins A; Martin GP; Bowes J; Lyons RA; Barton A; Peek N BMJ Open; 2024 Jun; 14(6):e079169. PubMed ID: 38904124 [TBL] [Abstract][Full Text] [Related]
6. The global challenges and opportunities in the practice of rheumatology: white paper by the World Forum on Rheumatic and Musculoskeletal Diseases. Al Maini M; Adelowo F; Al Saleh J; Al Weshahi Y; Burmester GR; Cutolo M; Flood J; March L; McDonald-Blumer H; Pile K; Pineda C; Thorne C; Kvien TK Clin Rheumatol; 2015 May; 34(5):819-29. PubMed ID: 25501633 [TBL] [Abstract][Full Text] [Related]
7. Prevalence of musculoskeletal conditions in an Italian population sample: results of a regional community-based study. I. The MAPPING study. Salaffi F; De Angelis R; Grassi W; ; Clin Exp Rheumatol; 2005; 23(6):819-28. PubMed ID: 16396700 [TBL] [Abstract][Full Text] [Related]
8. Impact of Chronic Diseases and Multimorbidity on Health and Health Care Costs: The Additional Role of Musculoskeletal Disorders. van der Zee-Neuen A; Putrik P; Ramiro S; Keszei A; de Bie R; Chorus A; Boonen A Arthritis Care Res (Hoboken); 2016 Dec; 68(12):1823-1831. PubMed ID: 27111195 [TBL] [Abstract][Full Text] [Related]
10. Effects of diet on the outcomes of rheumatic and musculoskeletal diseases (RMDs): systematic review and meta-analyses informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs. Gwinnutt JM; Wieczorek M; Rodríguez-Carrio J; Balanescu A; Bischoff-Ferrari HA; Boonen A; Cavalli G; de Souza S; de Thurah A; Dorner TE; Moe RH; Putrik P; Silva-Fernández L; Stamm T; Walker-Bone K; Welling J; Zlatković-Švenda M; Guillemin F; Verstappen SMM RMD Open; 2022 Jun; 8(2):. PubMed ID: 35654458 [TBL] [Abstract][Full Text] [Related]
11. Clinical features of patients with rheumatic and musculoskeletal diseases during the coronavirus disease 2019 pandemic and the association of its relapse with infection: Across-sectional study. Zhang Y; Xu P; Huang J; Hu Z Int J Rheum Dis; 2024 Apr; 27(4):e15150. PubMed ID: 38661306 [TBL] [Abstract][Full Text] [Related]
12. Costs, outcomes, and patient satisfaction by provider type for patients with rheumatic and musculoskeletal conditions: a critical review of the literature and proposed methodologic standards. Solomon DH; Bates DW; Panush RS; Katz JN Ann Intern Med; 1997 Jul; 127(1):52-60. PubMed ID: 9214253 [TBL] [Abstract][Full Text] [Related]
13. Prevalence of rheumatic and musculoskeletal diseases and their impact on health-related quality of life, physical function and mental health in Portugal: results from EpiReumaPt- a national health survey. Branco JC; Rodrigues AM; Gouveia N; Eusébio M; Ramiro S; Machado PM; da Costa LP; Mourão AF; Silva I; Laires P; Sepriano A; Araújo F; Gonçalves S; Coelho PS; Tavares V; Cerol J; Mendes JM; Carmona L; Canhão H; RMD Open; 2016; 2(1):e000166. PubMed ID: 26848402 [TBL] [Abstract][Full Text] [Related]
14. Living with foot and ankle disorders in rheumatic and musculoskeletal diseases: A systematic review of qualitative studies to inform the work of the OMERACT Foot and Ankle Working Group. Chapman LS; Flurey CA; Redmond AC; Richards P; Hofstetter C; Tapster B; Emmel J; Helliwell PS; Menz HB; Hannan MT; Shea B; Siddle HJ Semin Arthritis Rheum; 2023 Aug; 61():152212. PubMed ID: 37207417 [TBL] [Abstract][Full Text] [Related]
15. 2021 EULAR recommendations regarding lifestyle behaviours and work participation to prevent progression of rheumatic and musculoskeletal diseases. Gwinnutt JM; Wieczorek M; Balanescu A; Bischoff-Ferrari HA; Boonen A; Cavalli G; de Souza S; de Thurah A; Dorner TE; Moe RH; Putrik P; Rodríguez-Carrio J; Silva-Fernández L; Stamm T; Walker-Bone K; Welling J; Zlatković-Švenda MI; Guillemin F; Verstappen SMM Ann Rheum Dis; 2023 Jan; 82(1):48-56. PubMed ID: 35260387 [TBL] [Abstract][Full Text] [Related]
16. Trends for opioid prescribing and the impact of the COVID-19 pandemic in patients with rheumatic and musculoskeletal diseases between 2006 and 2021. Huang YT; Jenkins DA; Yimer BB; Benitez-Aurioles J; Peek N; Lunt M; Dixon WG; Jani M Rheumatology (Oxford); 2024 Apr; 63(4):1093-1103. PubMed ID: 37432340 [TBL] [Abstract][Full Text] [Related]
17. A global perspective on the challenges and opportunities in learning about rheumatic and musculoskeletal diseases in undergraduate medical education : White paper by the World Forum on Rheumatic and Musculoskeletal Diseases (WFRMD). Al Maini M; Al Weshahi Y; Foster HE; Chehade MJ; Gabriel SE; Saleh JA; Al Wahshi H; Bijlsma JWJ; Cutolo M; Lakhanpal S; Venkatramana M; Pineda C; Woolf AD Clin Rheumatol; 2020 Mar; 39(3):627-642. PubMed ID: 31127461 [TBL] [Abstract][Full Text] [Related]
18. Effects of physical exercise and body weight on disease-specific outcomes of people with rheumatic and musculoskeletal diseases (RMDs): systematic reviews and meta-analyses informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs. Gwinnutt JM; Wieczorek M; Cavalli G; Balanescu A; Bischoff-Ferrari HA; Boonen A; de Souza S; de Thurah A; Dorner TE; Moe RH; Putrik P; Rodríguez-Carrio J; Silva-Fernández L; Stamm T; Walker-Bone K; Welling J; Zlatković-Švenda MI; Guillemin F; Verstappen SMM RMD Open; 2022 Mar; 8(1):. PubMed ID: 35361692 [TBL] [Abstract][Full Text] [Related]
19. Outcomes of SARS-CoV-2 infection among children and young people with pre-existing rheumatic and musculoskeletal diseases. Kearsley-Fleet L; Chang ML; Lawson-Tovey S; Costello R; Fingerhutová Š; Švestková N; Belot A; Aeschlimann FA; Melki I; Koné-Paut I; Eulert S; Kallinich T; Berkun Y; Uziel Y; Raffeiner B; Oliveira Ramos F; Clemente D; Dackhammar C; Wulffraat NM; Waite H; Strangfeld A; Mateus EF; Machado PM; ; ; Natter M; Hyrich KL Ann Rheum Dis; 2022 Jul; 81(7):998-1005. PubMed ID: 35338032 [TBL] [Abstract][Full Text] [Related]
20. Social gradients in health and social care costs: Analysis of linked electronic health records in Kent, UK. Jayatunga W; Asaria M; Belloni A; George A; Bourne T; Sadique Z Public Health; 2019 Apr; 169():188-194. PubMed ID: 30876723 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]